Skip to main content
Premium Trial:

Request an Annual Quote

PrecisionLife Acquires Danish Collaborator GenoKey

NEW YORK — PrecisionLife said on Wednesday that it has acquired Danish genomic analytics firm GenoKey.

PrecisionLife said that it has worked with GenoKey, which is now a wholly owned subsidiary, on the development of the technology underlying its flagship artificial intelligence-driven bioinformatics platform for biomarker discovery and drug target validation. 

"The acquisition of GenoKey solidifies a long-term, highly productive collaboration around core IP and positions PrecisionLife for its next round of investment and growth," PrecisionLife CEO Steve Gardner said in a statement.

Following the acquisition, UK-based PrecisionLife said it will keep its core platform development operations at GenoKey's site in Denmark, which it plans to expand with additional hires. GenoKey Cofounder and Chairman Hans-Christian Brahe Møller will join the board of the new subsidiary.

Financial and other terms of the acquisition were not disclosed.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.